• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

性别对功能性二尖瓣反流经导管缘对缘修复术后死亡率的影响。

Impact of Gender on Mortality After Transcatheter Edge-to-Edge Repair for Functional Mitral Regurgitation.

机构信息

Division of Cardiology, Teikyo University Hospital, Tokyo, Japan.

Division of Cardiology, Teikyo University Hospital, Tokyo, Japan.

出版信息

Am J Cardiol. 2023 Oct 15;205:12-19. doi: 10.1016/j.amjcard.2023.07.143. Epub 2023 Aug 12.

DOI:10.1016/j.amjcard.2023.07.143
PMID:37579655
Abstract

Recent studies suggested short-term mortality after transcatheter edge-to-edge repair (TEER) was comparable between men and women. However, the gender-specific prognostic difference in the long-term follow-up after TEER is still unknown. To evaluate the impact of gender on long-term mortality after TEER for functional mitral regurgitation (FMR) using multicenter registry data. We retrospectively analyzed 1,233 patients (male 60.3%) who underwent TEER for FMR at 24 centers. The impact of gender on all-cause death and hospitalization for heart failure (HF) after TEER was evaluated using multivariate regression analysis and propensity score (PS) matching methods. During the 2-year follow-up, 207 all-cause death and 263 hospitalizations for HF were observed after TEER for FMR. Men had a significantly higher incidence of all-cause death than women (18.6% vs 14.1%, log-rank p = 0.03). After adjustment by multivariate Cox regression and PS matching, the male gender was significantly associated with a higher incidence of all-cause mortality after TEER than the female gender (hazard ratio 2.11, 95% confidence interval 1.42 to 3.14 in multivariate Cox regression; hazard ratio 1.89, 95% confidence interval 1.03 to 3.48 in PS matching). The gender-specific prognostic difference was even more pronounced after 1-year of TEER. On the contrary, there was no gender-related difference in hospitalization for HF after TEER. In conclusion, women with FMR had a better prognosis after TEER than men, whereas this was not observed in hospitalization for HF. This result might indicate that women with FMR are more likely to benefit from TEER.

摘要

最近的研究表明,经导管缘对缘修复(TEER)后短期死亡率在男性和女性之间相当。然而,TEER 后长期随访中性别特异性预后差异尚不清楚。本研究旨在使用多中心注册数据评估性别对功能性二尖瓣反流(FMR)患者 TEER 后长期死亡率的影响。我们回顾性分析了 24 个中心的 1233 例行 TEER 治疗 FMR 的患者(男性占 60.3%)。使用多变量回归分析和倾向评分(PS)匹配方法评估性别对 TEER 后全因死亡和心力衰竭(HF)住院的影响。在 2 年的随访期间,观察到 207 例全因死亡和 263 例 HF 住院。男性全因死亡率明显高于女性(18.6%比 14.1%,log-rank p=0.03)。多变量 Cox 回归和 PS 匹配校正后,男性性别与 TEER 后全因死亡率升高显著相关(多变量 Cox 回归中 HR 为 2.11,95%CI 为 1.42 至 3.14;PS 匹配中 HR 为 1.89,95%CI 为 1.03 至 3.48)。TEER 后 1 年时性别特异性预后差异更为明显。相反,TEER 后 HF 住院无性别相关差异。总之,FMR 女性患者 TEER 后预后优于男性,而 HF 住院则不然。这一结果可能表明 FMR 女性患者更可能从 TEER 中获益。

相似文献

1
Impact of Gender on Mortality After Transcatheter Edge-to-Edge Repair for Functional Mitral Regurgitation.性别对功能性二尖瓣反流经导管缘对缘修复术后死亡率的影响。
Am J Cardiol. 2023 Oct 15;205:12-19. doi: 10.1016/j.amjcard.2023.07.143. Epub 2023 Aug 12.
2
Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial.伴有继发性二尖瓣反流和心力衰竭患者的住院和死亡情况:COAPT 试验。
J Am Coll Cardiol. 2022 Nov 15;80(20):1857-1868. doi: 10.1016/j.jacc.2022.08.803.
3
Outcomes After Transcatheter Edge-to-Edge Mitral Valve Repair According to Mitral Regurgitation Etiology and Cardiac Remodeling.根据二尖瓣反流病因和心脏重构的经导管缘对缘二尖瓣修复术后的结果。
JACC Cardiovasc Interv. 2022 Sep 12;15(17):1711-1722. doi: 10.1016/j.jcin.2022.07.004.
4
Outcomes in Patients With High Transmitral Gradient After Mitral Valve Transcatheter Edge-to-Edge Repair for Mitral Regurgitation.二尖瓣反流经导管缘对缘修复术后高二尖瓣跨瓣梯度患者的结局。
Am J Cardiol. 2022 Nov 1;182:46-54. doi: 10.1016/j.amjcard.2022.07.036. Epub 2022 Sep 6.
5
Transcatheter mitral valve replacement or repair for secondary mitral regurgitation: a propensity score-matched analysis.经导管二尖瓣置换或修复治疗继发性二尖瓣反流:一项倾向评分匹配分析。
Eur J Heart Fail. 2023 Mar;25(3):399-410. doi: 10.1002/ejhf.2797. Epub 2023 Mar 8.
6
Transcatheter Edge-to-Edge Repair in Proportionate Versus Disproportionate Functional Mitral Regurgitation.经皮缘对缘修复术治疗比例性与非比例性功能性二尖瓣反流。
J Am Soc Echocardiogr. 2022 Jan;35(1):105-115.e8. doi: 10.1016/j.echo.2021.08.002. Epub 2021 Aug 11.
7
Mitral Valve Transcatheter Edge-to-Edge Repair After TAVR: A Nationwide Analysis.经导管主动脉瓣置换术(TAVR)后二尖瓣瓣环成形术的全国性分析。
Am J Cardiol. 2023 Dec 15;209:184-189. doi: 10.1016/j.amjcard.2023.09.089. Epub 2023 Oct 16.
8
Predictors of mortality in ischaemic versus non-ischaemic functional mitral regurgitation after successful transcatheter mitral valve repair using MitraClip: results from two high-volume centres.经导管二尖瓣修复术后缺血性与非缺血性功能性二尖瓣反流患者的死亡率预测因素:来自两个大容量中心的结果。
Clin Res Cardiol. 2019 Mar;108(3):264-272. doi: 10.1007/s00392-018-1352-x. Epub 2018 Aug 10.
9
Incidence, Predictors, and Outcomes Associated With Worsening Renal Function in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial.心力衰竭合并继发性二尖瓣反流患者肾功能恶化的发生率、预测因素和转归:COAPT 试验。
J Am Heart Assoc. 2023 Jul 18;12(14):e029504. doi: 10.1161/JAHA.123.029504. Epub 2023 Jul 8.
10
Outcomes Stratified by Adapted Inclusion Criteria After Mitral Edge-to-Edge Repair.按改良纳入标准分层的二尖瓣缘对缘修复术后结局。
J Am Coll Cardiol. 2021 Dec 14;78(24):2408-2421. doi: 10.1016/j.jacc.2021.10.011.

引用本文的文献

1
Identifying Responders to Transcatheter Interventions for Secondary Mitral Regurgitation.识别二尖瓣反流继发性经导管介入治疗的反应者。
Curr Treat Options Cardiovasc Med. 2025;27(1):54. doi: 10.1007/s11936-025-01095-1. Epub 2025 Jul 31.
2
Transcatheter Structural Heart Interventions in Women.女性经导管结构性心脏病介入治疗
Curr Cardiol Rep. 2025 Jul 23;27(1):118. doi: 10.1007/s11886-025-02254-3.
3
Sex-Specific Disparities in Outcomes of Transcatheter Edge-to-Edge Repair for Mitral Regurgitation: A Multicenter "Real-World" Analysis.
经导管二尖瓣反流缘对缘修复术结局的性别差异:一项多中心“真实世界”分析
J Clin Med. 2023 Nov 22;12(23):7231. doi: 10.3390/jcm12237231.